{"id":"https://openalex.org/W1991342575","doi":"https://doi.org/10.1111/ane.12080","title":"Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety","display_name":"Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety","publication_year":2013,"publication_date":"2013-01-11","ids":{"openalex":"https://openalex.org/W1991342575","doi":"https://doi.org/10.1111/ane.12080","mag":"1991342575","pmid":"https://pubmed.ncbi.nlm.nih.gov/23311457"},"language":"en","primary_location":{"id":"doi:10.1111/ane.12080","doi":"https://doi.org/10.1111/ane.12080","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ane.12080","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12080","source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12080","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054865768","display_name":"Stella Marousi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"S. Marousi","raw_affiliation_strings":["Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","Tel.: 0030 6972009400"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","institution_ids":["https://openalex.org/I4210105465"]},{"raw_affiliation_string":"Tel.: 0030 6972009400","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073254534","display_name":"I. Karkanis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"I. Karkanis","raw_affiliation_strings":["Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","institution_ids":["https://openalex.org/I4210105465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050365401","display_name":"T. Kalamatas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"T. Kalamatas","raw_affiliation_strings":["Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","institution_ids":["https://openalex.org/I4210105465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045710105","display_name":"Maria Travasarou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"M. Travasarou","raw_affiliation_strings":["Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","institution_ids":["https://openalex.org/I4210105465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103095692","display_name":"Georgios S. Paterakis","orcid":"https://orcid.org/0000-0001-9299-8346","observed_orcids":["https://orcid.org/0000-0001-9299-8346"]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"G. Paterakis","raw_affiliation_strings":["Department of Heamatology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Heamatology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","institution_ids":["https://openalex.org/I4210105465"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113595739","display_name":"Clementine E. Karageorgiou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"C. E. Karageorgiou","raw_affiliation_strings":["Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology; \u2018G. Gennimatas\u2019 General Hospital of Athens; Athens; Greece","institution_ids":["https://openalex.org/I4210105465"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054865768"],"corresponding_institution_ids":["https://openalex.org/I4210105465"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":null,"fwci":1.78,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.84068945,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"128","issue":"1","first_page":"e1","last_page":"e5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.890999972820282},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.796999990940094},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.949999988079071},{"id":"https://openalex.org/keywords/nkt-cells","display_name":"NKT cells","score":0.9419999718666077},{"id":"https://openalex.org/keywords/desensitization","display_name":"desensitization","score":0.703000009059906},{"id":"https://openalex.org/keywords/progressive-multifocal-leukoencephalopathy","display_name":"progressive multifocal leukoencephalopathy","score":0.871999979019165},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.7509999871253967},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.7929999828338623},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.8584014773368835},{"id":"https://openalex.org/C182516595","wikidata":"https://www.wikidata.org/wiki/Q376660","display_name":"Nat","level":2,"score":0.739704966545105},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7055798172950745},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6297610402107239},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5774113535881042},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5313155055046082},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5278717875480652},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46435976028442383},{"id":"https://openalex.org/C2909287720","wikidata":"https://www.wikidata.org/wiki/Q28456127","display_name":"CD4-CD8 Ratio","level":5,"score":0.43450841307640076},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.41316521167755127},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34098905324935913},{"id":"https://openalex.org/C3020391436","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte subsets","level":4,"score":0.20338565111160278},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/ane.12080","doi":"https://doi.org/10.1111/ane.12080","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ane.12080","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12080","source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmid:23311457","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23311457","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica","raw_type":"Controlled Clinical Trial"}],"best_oa_location":{"id":"doi:10.1111/ane.12080","doi":"https://doi.org/10.1111/ane.12080","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ane.12080","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12080","source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W1991342575.pdf"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1562235305","https://openalex.org/W1963521120","https://openalex.org/W1969968445","https://openalex.org/W1981263092","https://openalex.org/W2013521780","https://openalex.org/W2023211244","https://openalex.org/W2044022462","https://openalex.org/W2069416484","https://openalex.org/W2097025094","https://openalex.org/W2103758700","https://openalex.org/W2138223843","https://openalex.org/W2140422101","https://openalex.org/W2151575412","https://openalex.org/W2152504521","https://openalex.org/W2169082675"],"related_works":["https://openalex.org/W1533891480","https://openalex.org/W2612586229","https://openalex.org/W4389412035","https://openalex.org/W2011257051","https://openalex.org/W2904124868","https://openalex.org/W2097025094","https://openalex.org/W2320480953","https://openalex.org/W2057903396","https://openalex.org/W1964847228","https://openalex.org/W2169082675"],"abstract_inverted_index":{"BACKGROUND:":[0],"Previous":[1],"studies":[2],"on":[3],"Natalizumab":[4],"(NAT)":[5],"have":[6],"shown":[7],"increased":[8],"circulation":[9],"of":[10,37,80,123,139],"most":[11,174],"white":[12],"blood":[13],"cells":[14],"(WBC)":[15],"in":[16,57,68,110],"multiple":[17],"sclerosis":[18],"(MS)":[19],"patients":[20,60,75,112,172],"shortly":[21],"after":[22,32,155],"its":[23],"introduction.":[24],"AIM:":[25],"To":[26],"describe":[27],"peripheral":[28],"immune":[29,52],"cell":[30,53],"phenotypes":[31],"more":[33,91],"than":[34],"2":[35],"years":[36],"continuous":[38],"NAT":[39,62,124,157],"therapy":[40],"and":[41,67,99,116,142],"test":[42],"for":[43,63,184,195,198,213],"associations":[44],"with":[45,85,96,120,165],"clinical":[46],"response":[47,167],"to":[48,132,168,206],"therapy.":[49],"METHODS:":[50],"Peripheral":[51],"subsets":[54],"were":[55],"analyzed":[56],"44":[58],"NAT-MS":[59,74,111],"receiving":[61],"over":[64],"24":[65],"months,":[66],"22":[69],"NAT-free":[70],"control-MS":[71],"patients.":[72],"RESULTS:":[73],"displayed":[76],"significantly":[77,108],"higher":[78],"numbers":[79],"all":[81],"WBC":[82],"when":[83,94],"compared":[84,95],"controls.":[86],"B":[87],"lymphocytes":[88],"exhibited":[89],"a":[90,203],"pronounced":[92],"increase":[93],"CD4+,":[97],"CD8+":[98],"NK":[100],"T-cells":[101],"(P":[102,113],"=":[103,114],"0.011).":[104],"CD4/CD8":[105,128,161,200],"ratio":[106,129,162,201],"was":[107,130,163],"decreased":[109],"0.018)":[115],"showed":[117],"no":[118,152],"correlation":[119],"the":[121,133,177,199,207],"number":[122],"doses.":[125],"The":[126,146],"reduced":[127,160],"attributable":[131],"'EDSS":[134],"improvement'":[135],"group":[136],"only,":[137],"irrespective":[138],"age,":[140],"sex":[141],"disease":[143],"severity.":[144],"CONCLUSIONS:":[145],"study":[147],"suggests":[148],"that":[149],"there":[150],"is":[151],"desensitization":[153],"effect":[154],"prolonged":[156],"exposure.":[158],"A":[159],"associated":[164],"long-term":[166],"therapy;":[169],"thus,":[170],"those":[171],"who":[173],"benefitted":[175],"from":[176],"drug":[178],"might":[179],"be":[180],"at":[181],"greater":[182],"risk":[183,210],"opportunistic":[185],"infections":[186],"like":[187],"progressive":[188],"multifocal":[189],"leucoencephalopathy":[190],"(PML).":[191],"We":[192],"provide":[193],"implications":[194],"future":[196],"research":[197],"as":[202],"possible":[204],"contributor":[205],"recently":[208],"developed":[209],"stratification":[211],"scheme":[212],"PML.":[214]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}